Q
QuantLogix.ai
Weekly Market Briefing
Week in Review · June 8 – June 12, 2026

Peace Bid Salvages a Choppy Week as Chips Whipsaw and Sticky Inflation Locks the Fed in Place

A 9-week S&P 500 winning streak snapped on a hot CPI print and a brutal mid-week semiconductor washout, but a late-week Iran de-escalation, a record Oracle cloud quarter, and an Adobe guide-up rescued indices into the close. Defense led, biotech lagged, and the Fed enters next week's meeting boxed in by 4.2% headline inflation.

Published Friday, June 12, 2026 · 5:30 PM ET
S&P 500
7,394.30
+0.6% week
Nasdaq Composite
25,709
–4.2% mid-week shock
Dow Jones
+0.40%
Friday close
VIX
19.25
–0.98% intraday
10-Yr Treasury
4.52%
5-wk avg
Fed Funds Target
3.50–3.75%
96.3% hold odds
CPI (May, YoY)
4.2%
3-yr high
ITA Defense ETF
+4.97%
Week leader
Market Recap Macro & Fed Technology & AI Defense Biotech Week Ahead
Section 01 · Equities

The Week That Ended a Streak

Equities entered the week riding a nine-week S&P 500 winning streak, then promptly hit a wall. A Wednesday Broadcom print delivered a softer-than-expected AI chip outlook and triggered the worst session for semiconductors since the March 2020 covid plunge, dragging the Nasdaq down 4.18% on Thursday June 4 and erasing more than $1 trillion of market cap in two sessions. Micron fell 17%, AMD 12.6%, and Intel 9% over the two-day washout.

Sentiment flipped sharply on Wednesday June 10 when the White House cancelled planned strikes against Iran and signaled a peace framework was within reach. The reversal sparked the Nasdaq's best single day since March, with chipmakers leading the bounce. By Friday's close, the S&P 500 had clawed back to a +0.6% weekly gain at 7,394.30, the Dow added 0.40%, and the Nasdaq finished flat-to-down as profit-taking ahead of the SpaceX IPO weighed on growth names.

Breadth told a friendlier story than the cap-weighted tape: the S&P equal-weight rose almost 2% with nine of eleven sectors higher, while mega-cap growth fell about 1%. Defense, energy, and industrials led; semiconductors and biotech lagged.

Index / Asset Friday Close Weekly Change Driver
S&P 5007,394.30+0.6%Peace bid & equal-weight breadth
Nasdaq Composite25,709MixedChip washout offset by Wed bounce
Dow Industrials+0.40% FriIndustrials & defense leadership
VIX19.25Off mid-March 30+ peakIran de-escalation
10-Yr Treasury~4.52%Range 4.41–4.69Hot CPI, jobs strength
WTI CrudeTumbled FriSharp dropHormuz reopening hopes
Bottom Line

The streak ended, but the index didn't break. Rotation under the surface — defense and equal-weight leading mega-cap growth — is the cleanest signal of a market re-pricing for stickier inflation and a Fed on hold.

Section 02 · Macro

The Inflation Problem the Fed Cannot Fix

May CPI landed at +0.5% month-over-month and +4.2% year-over-year, the hottest headline reading since April 2023. The pain was almost entirely energy: gasoline and electricity jumped 3.9% on the month and 23.5% over the trailing year as the effective closure of the Strait of Hormuz since late February throttled global crude supply.

Core CPI was the silver lining — +0.2% m/m, +2.9% y/y, the lowest annual core read in over a year and a sign that demand-side inflation is not re-accelerating. The split sets up an awkward FOMC meeting on June 17: headline tells the Fed to stand firm; core tells it the underlying disinflation thesis is intact. Futures markets agree — CME FedWatch puts the probability of holding at 3.50–3.75% next Wednesday at 96.3%, with rate-hike odds now slightly higher than cut odds for the fall.

Friday's oil collapse on Iran peace headlines is the single most important macro signal of the week. A durable reopening of the Strait of Hormuz would mechanically reverse the headline CPI surge over the next two-to-three prints — exactly the cover the Fed needs to pivot dovish into Q4.

Bottom Line

Sticky headline + softening core + a peace bid is the most bullish macro setup the market has seen since February. The risk is that any breakdown in talks instantly re-prices oil, yields, and the entire risk-on trade.

Section 03 · Sector Deep Dive

Technology & AI: Broadcom Cracks the Tape, Oracle & Adobe Save It

The week's defining tech story was the AI-chip air pocket. Broadcom's softer guide triggered indiscriminate selling across the semiconductor complex; the Philadelphia SE Semiconductor Index logged its worst single-day percentage drop since the March 2020 crash. Micron –17%, AMD –12.6%, Intel –9%, Marvell –8%, Nvidia and AVGO each off mid-single-digits in the two-day window.

The hyperscaler-tier AI story, however, came roaring back with two of the most important enterprise prints of the year:

Oracle (ORCL) delivered a genuinely historic Q4: revenue $19.2B (+21%), total cloud $9.9B (+47%), OCI infrastructure $5.8B (+93%). The headline number was Remaining Performance Obligations of $638 billion, up 363% y/y and $85B sequentially — almost entirely from large pre-paid AI training contracts. Management guided FY27 cloud growth of 57–63% in constant currency and raised non-GAAP EPS to $8.05.

Adobe (ADBE) posted Q2 revenue of $6.62B (+13% y/y) with total ARR exiting at $27.10B including ~$480M from Semrush. Non-GAAP EPS of $5.96 beat consensus and management raised both the FY revenue and EPS targets. GenAI monetization across Firefly and Express is finally landing in the print.

ThemeReadImplication
AI Capex DemandOracle RPO +363%Hyperscaler training spend uninterrupted
AI Chip SentimentBroadcom guide spooks StreetSentiment fragile; concentration risk exposed
Enterprise SaaSAdobe ARR $27.1B, guide-upAI monetization is now a P&L line, not a slide
Mega-Cap GrowthDown ~1% on weekRotation into equal-weight underway
Bottom Line

The bifurcation is now obvious: AI infrastructure demand at the hyperscaler tier (Oracle, AVGO, NVDA) is structural; sentiment in the merchant-silicon and memory tier (Micron, AMD, Intel) is cyclical and headline-driven. Position size accordingly.

Section 04 · Sector Deep Dive

Defense: The Cleanest Beta in the Tape

The iShares Aerospace & Defense ETF (ITA) closed the week up +4.97%, the strongest performer among the major sector ETFs and the cleanest macro hedge of the year-to-date. The sector caught a paradoxical bid: defense names rallied both on Iran escalation fears earlier in the week and on the peace bid Wednesday, because a reopened Hormuz still implies multi-year regional re-armament, NATO replenishment, and elevated munitions procurement.

Headline catalysts:

Lockheed Martin (LMT) opened its Next Generation Interceptor facility in Courtland, Alabama on June 1, anchoring the integrated missile defense story. The F-35 program plus a $160B+ backlog makes LMT the highest-revenue-visibility name in the group. RTX remains the cleanest near-term munitions replenishment play, with the largest order book in the industry and dual commercial-defense exposure. Northrop Grumman (NOC) is entering the final test phase of the B-21 Raider; first deliveries expected in 2026. Palantir (PLTR) continues to bridge the traditional defense and tech-defense ETFs (6.54% weight in SHLD).

Valuation discipline matters here: the prime contractors now trade at 22–25x forward earnings, a premium to the S&P and well above their 10-year averages. The sector is priced for the multi-year buildout to actually arrive.

Bottom Line

Defense is the rare sector where both war and peace are bullish — and that asymmetry is exactly why it led the tape this week. Watch the June 17 NATO spending headlines for the next leg.

Section 05 · Sector Deep Dive

Biotech: Technicals Roll Over, Fundamentals Still Constructive

The SPDR S&P Biotech ETF (XBI) entered a clear technical breakdown this week. MACD turned negative on June 2, momentum dropped below zero on June 5, the price broke its 50-day moving average that same session, and on June 9 the 10-day MA crossed bearishly below the 50-day — a classic short-term sell signal. The setup mirrors prior mid-cycle pauses inside broader bull runs and is partly a flight-to-quality rotation as rate expectations re-firm.

Underneath the chart damage, fundamentals remain the most constructive they've been in three years. Trailing-twelve-month returns are XBI +40.8% and IBB +33.95%. M&A activity is accelerating as large pharma faces a $200B+ patent cliff through 2030, and AI-enabled drug discovery is a tailwind for early-stage names.

Eli Lilly (LLY) remains the heavyweight: the FDA approved its oral obesity drug Foundayo, and oral orforglipron is tracking to a late-2026 approval that would expand the GLP-1 franchise into a pill format. Vertex (VRTX) reported $2.24B in CF franchise sales, beating consensus on the back of the April pediatric label expansion. Moderna (MRNA) is targeting a 2026 BLA refile following the May 2025 withdrawal, supported by $1.5B in November 2025 financing.

Bottom Line

XBI is a tactical pause inside a structural bull case. Use the technical reset to build positions in large-cap obesity (LLY), rare-disease (VRTX), and high-conviction takeout candidates rather than chase the next bounce in the index.

Section 06 · Forward Calendar

The Week Ahead — All Eyes on the Fed

The June 15–19 calendar is dominated by the FOMC decision on Wednesday June 17, where the Fed is overwhelmingly expected to hold at 3.50–3.75%. The market reaction function will hinge entirely on the Summary of Economic Projections dot plot and Chair Powell's read on the May CPI energy surge — does the Committee see Hormuz-driven inflation as transitory enough to look through, or does it pull the next cut further into Q4?

Beyond the Fed, watch the SpaceX IPO pricing dynamics for read-through to growth-equity risk appetite, retail sales on Tuesday June 16 for consumer health, and the next round of Iran negotiation headlines for any reversal of Friday's oil-price relief.

DateEventWhy It Matters
Tue Jun 16US Retail Sales (May)Consumer durability vs. inflation pinch
Wed Jun 17FOMC Decision & SEPHold expected; dot plot is the trade
Wed Jun 17Powell Press ConferenceForward guidance on cut path
Thu Jun 18Initial Jobless ClaimsLabor market check post-strong May NFP
OngoingIran negotiationsOil & risk-on / risk-off switch